We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Local Anesthesia Holds Benefits Following Knee Replacement Surgery

By HospiMedica International staff writers
Posted on 01 Mar 2012
Intraarticular delivery of local anesthesia through a catheter may be more beneficial than traditional opioids for managing pain following total knee replacement (TKR) surgery, according to a new study.

Researchers at Thomas Jefferson University Hospital (Philadelphia, PA, USA) conducted a double-blind trial involving 150 primary, unilateral knee replacement patients that were administered either bupivacaine (a common analgesic), or normal saline intraoperatively through a catheter in the joint, which released fluid continually over two postoperative days. More...
The patients were asked to complete questionnaires at 5 PM on the day of surgery and 8 AM and 5 PM each day until discharge, as well as at a four-week follow-up visit.

The initial study results demonstrated that the patients who received bupivacaine had the least pain and the lowest narcotic consumption, with no significant different in postoperative complications and no increase in infection risk. The researchers concluded that intraarticular delivery could provide an effective alternative for pain relief in the immediate postoperative time period without the disadvantages encountered with epidural anesthesia, regional nerve blockade, and patient controlled analgesia pumps. The study was presented at the American Academy of Orthopedic Surgeons (AAOS) annual meeting, held during February 2012 in San Francisco (CA, USA).

“This study opens up a potential new option for better pain management postsurgery for our knee replacement patients. Though further study is needed, these initial results are promising,” said study presenter and coauthor Nitin Goyal, MD.

Postoperative pain control after TKR arthroplasty is a well-known clinical problem. Efforts to treat it with the use of local anesthesia have been made, but the results have been contradictive. In the late 1990s, it was shown that an infiltrated solution of ropivacaine, ketorolac, and adrenaline was effective for this purpose, and this technique has since spread over the world.

Related Links:
Thomas Jefferson University Hospital


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Absorbable Monofilament Mesh
Phasix Mesh
Mobile X-Ray System
K4W
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.